Verastem, Inc., (NASDAQ:VSTM) focused on discovering and developing
drugs to treat cancer by the targeted killing of cancer stem cells,
announced that members of the management team will be presenting at
upcoming investor conferences. The presentation details are as follows:
-
UBS Global Healthcare Conference on Monday, May 19, 2014, at 3:30 p.m.
ET at the Sheraton New York Hotel in New York City
-
Jefferies Global Healthcare Conference on Wednesday, June 4, 2014 at
2:00 p.m. ET in New York City
Webcasts of the conference presentations can be accessed by visiting the
investors section of the Company’s website at www.verastem.com.
Replays of the webcasts will be archived on the Verastem website for 90
days following the presentation date.
About Verastem, Inc.
Verastem, Inc. (NASDAQ:VSTM) is discovering and developing drugs to
treat cancer by the targeted killing of cancer stem cells. Cancer stem
cells are an underlying cause of tumor recurrence and metastasis.
Verastem is developing small molecule inhibitors of signaling pathways
that are critical to cancer stem cell survival and proliferation: FAK,
PI3K/mTOR and Wnt. For more information, please visit
Forward-looking statements:
Any statements in this press release about future expectations, plans
and prospects for the Company constitute forward-looking statements
within the meaning of The Private Securities Litigation Reform Act of
1995. Actual results may differ materially from those indicated by such
forward-looking statements. The Company anticipates that subsequent
events and developments will cause the Company’s views to change.
However, while the Company may elect to update these forward-looking
statements at some point in the future, the Company specifically
disclaims any obligation to do so.
Copyright Business Wire 2014